Do not forget the original Phenoxodiol under Kelly's original Novogen and its subsidiary Marshall Edwards that had been "proven to work" and then blew up costing many people millions of $$$. Do not count on it until they have patents issued, a deal and an FDA approval. Multiple hard lessons learned in terms of inexact science, trial design, the way data is reported, people, their motives, over selling and believing too much. GLTA
- Forums
- ASX - By Stock
- NOX
- Ann: Noxopharm IONIC Immuno-Oncology Trial Commences
Ann: Noxopharm IONIC Immuno-Oncology Trial Commences, page-10
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
0.014(14.6%) |
Mkt cap ! $32.14M |
Open | High | Low | Value | Volume |
9.2¢ | 11.5¢ | 9.2¢ | $53.30K | 518.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 48681 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 74195 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 48681 | 0.100 |
1 | 7253 | 0.099 |
2 | 23340 | 0.092 |
1 | 10989 | 0.091 |
3 | 204710 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 69808 | 3 |
0.115 | 256630 | 6 |
0.120 | 61648 | 3 |
0.125 | 447472 | 6 |
0.130 | 199760 | 1 |
Last trade - 15.45pm 23/08/2024 (20 minute delay) ? |
NOX (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online